Clinical Trial Update: A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study evaluating TNFerade Biologic with radiotherapy, fluorouracil, and hydroxyurea in patients with head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• HYDROXYUREA (Hydroxyurea)
• TNFerade Biologic (TNFerade)

Snippet

Sponsor: GenVec | Conditions: Head and Neck Cancer, Head and Neck Neoplasms | Phase 1, Phase 2 | Status: COMPLETED